June 25, 2025 — Royal Philips and Methodist Hospitals recently announced the healthcare provider’s strategic investment ...
June 23, 2025 — GE HealthCare’s commitment to advancing precision care in cardiology through its molecular imaging ...
Despite advancements in ventricular arrhythmia (VA) screening, numerous high-profile athlete cases have highlighted the ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 16, 2025 – Penumbra, Inc. recently announced the completion of enrollment in the STORM-PE clinical trial. This ...
June 13, 2025 — An international study has shown that targeted online education on atrial fibrillation (AF) for health ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
June 11, 2025 — MorningStar Laboratories, LLC, a developer of precision diagnostic tests that address unmet clinical ...
June 04, 2025 — HeartSciences Inc. has announced that the U.S. Food and Drug Administration has granted Breakthrough ...
June 12, 2025 — Viz.ai recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
June 12, 2025 – The American Society of Echocardiography (ASE) and Cardiovascular Research Foundation (CRF) have ...
June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...
June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
As healthcare systems continue to shift toward value-based care and proactive disease management, remote monitoring has ...
June 6, 2025 – A large retrospective review of more than 100,000 patients found the use of glucagon-like peptide-1 ...
June 5, 2025 – Penumbra, Inc. has announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby ...
June 25, 2025
